Polski Bank Komorek Macierzystych (PBKM) operates a group of stem cell banks under the FamiCord Group brand. It also develops stem cell therapy for the treatment of a number of diseases. In this interview, Jakub Baran (President of the Management Board) provides the background to PBKM’s product and expected market developments, including the impact of COVID-19 on its distribution channels. He also discusses the company’s geographic expansion and current focus. He explains how PBKM is positioned for further growth. Finally, he sheds some light on develpments related to the company’s CAR-T project.